Health and Clinical Excellence bulletin: November 2007

In this issue:

• NICE issues public health guidance to help people change their behaviour and enjoy healthier lives;
• Bortezomib for the treatment of relapsed multiple myeloma;
• adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis;
• guidance issued in October;
• guidance expected in November.